Coe Capital Management’s Opko Health OPK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$203K Hold
50,000
0.19% 90
2021
Q1
$215K Buy
50,000
+13,500
+37% +$64.5K 0.22% 85
2020
Q4
$144K Buy
+36,500
New +$152K 0.16% 85
2016
Q4
Sell
-130,000
Closed -$1.24M 135
2016
Q3
$1.24M Sell
130,000
-14,400
-10% -$143K 0.4% 97
2016
Q2
$1.35M Sell
144,400
-30,000
-17% -$305K 0.47% 69
2016
Q1
$1.81M Sell
174,400
-25,000
-13% -$228K 0.58% 58
2015
Q4
$2M Buy
199,400
+62,400
+46% +$625K 0.8% 36
2015
Q3
$1.15M Sell
137,000
-68,000
-33% -$900K 0.43% 76
2015
Q2
$3.3M Hold
205,000
1.2% 14
2015
Q1
$2.9M Buy
205,000
+60,000
+41% +$781K 1.17% 20
2014
Q4
$1.45M Hold
145,000
0.46% 68
2014
Q3
$1.23M Buy
145,000
+15,000
+12% +$132K 0.46% 81
2014
Q2
$1.15M Sell
130,000
-19,000
-13% -$166K 0.41% 90
2014
Q1
$1.39M Sell
149,000
-50,741
-25% -$445K 0.41% 83
2013
Q4
$1.69M Sell
199,741
-1,000
-0.5% -$10.1K 0.59% 47
2013
Q3
$1.77M Buy
200,741
+20,741
+12% +$166K 1.18% 25
2013
Q2
$1.28M Buy
+180,000
New +$1.24M 0.49% 64

Other funds holding OPK

Coe Capital Management's OPK Position: Q2 2021 in Review

Coe Capital Management held its Opko Health (OPK) position steady in Q2 2021 at 50,000 shares worth $203K. The position accounts for 0.19% of the portfolio, ranked #90.

Coe Capital Management first reported a position in OPK in Q2 2013 and has held it in 17 quarters since. The position peaked at $3.3M in Q2 2015. 233 funds tracked by Wall St. Rank hold OPK as of Q2 2021.

  • Coe Capital Management held 50,000 shares of Opko Health worth $203K as of Q2 2021.
  • Coe Capital Management left its Opko Health share count unchanged in Q2 2021.
  • Opko Health made up 0.19% of Coe Capital Management's portfolio in Q2 2021, its #90 holding.
  • Coe Capital Management first reported a position in Opko Health in Q2 2013 and has held it in 17 quarters since.
  • Coe Capital Management's Opko Health position peaked at $3.3M in Q2 2015.
  • 233 funds tracked by Wall St. Rank held Opko Health as of Q2 2021.

Based on Coe Capital Management's 13F filing for Q2 2021, filed 22 Jul 2021.